Arkolith/Insider Trading/AXIM/Form 4

Schroeder Blake

DirectorAXIM BIOTECHNOLOGIES, INC. (AXIM) · full profile →Form 4 · filed Feb 15, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 10, 2022Other(J)25K$25000.00$625.0M308K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001096906-22-000339) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML